https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Cardiovascular

Showing 97–112 of 156 results

Vascular Access Devices Market Analysis, Size, Trends | Australia | 2017-2023 | MedSuite (Includes 7 Reports)

The Australian market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs) and dialysis catheters. In Australia, the use of PICCs has grown significantly at the expense of CVCs, whereas practitioners in Japan prefer to use CVCs. Moreover, nurse-led placement of PICCs has been a catalyst for increasing adoption of PICCs which significantly lowered overall procedural cost. The combination of these factors will result in overall unit sales growth in the PICC market over the forecast period.

more...

Vascular Access Devices Market Analysis, Size, Trends | India | 2017-2023 | MedSuite (Includes 7 Reports)

The Indian market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), and dialysis catheters. The Indian market is still undergoing frequent and drastic changes in terms of regulations, shaped by efforts to contain the growing healthcare budget and supporting market growth and development. Recently, the government has been adamant on clearing regulatory hurdles related to imports and exports of medical devices, and has set new standards around clinical trials. In addition, the Indian government runs several health insurance programs designed for high-risk patients to pay upfront cash and then get reimbursed by filing a claim. This process has proven inefficient and slow, and major improvements are possible if better payment mechanisms are implemented.

more...

Dialysis Catheters Market Analysis | China | 2017-2023 | MedCore

In 2016, the Chinese market for dialysis catheters increased over the previous year. The market for dialysis catheters is experiencing significant growth due to the growing incidence of end-stage renal disease and the need for dialysis. This growth has led to a dramatic rise in clinics offering dialysis. The growth has had a negative effect on the quality of care. In an effort to make profits, quality of care has deteriorated, with a significant percentage of hospitals and clinics not having dialysis specialists among their staff. The market for dialysis catheters will continue to grow as ASP growth for dialysis catheters remains steady at a low-single digit rate due to increased competition from low-cost producers from the local markets in China, as well as foreign competitors in Korea and India.

more...

Implantable Ports Market Analysis | China | 2017-2023 | MedCore

The Chinese market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. Currently, the conventional implantable ports segment accounted for about 65% of the total implantable ports market. Over the forecast period, the market breakdown is not expected to change by much.

more...

Peripherally Inserted Central Catheters Market Analysis | China | 2017-2023 | MedCore

The Chinese market for peripherally inserted central catheters (PICCs) is split up into two segments: power-injectable and non-power-injectable PICCs. Non-power-injectable PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties. Although power-injectable PICCs have become the standard of care in some countries such as the U.S., China still prefers conventional PICCs and is over ten years behind most developed countries. In 2016, power-injectable PICCs represented less than 25% of the total market for PICCs, with the remaining balance represented by non-power-injectable PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.

more...

Peripheral Intravenous Catheters Market Analysis | China | 2017-2023 | MedCore

The Chinese market for peripheral intravenous catheters (PIVCs) is split up into two segments: conventional PIVC and safety PIVC. PIVCs are inserted in veins and arteries. An arterial access site is utilized in patients that require blood pressure monitoring. Firmer catheters are preferred for arterial access. A venous access site is utilized for infusing fluids, providing antibiotic treatment and other standard procedures. In 2016, safety PIVCs represented less than 5% of the total market for PIVCs, with the remaining balance represented by conventional PIVCs. Growth in the unit sales of advanced materials PIVCs is expected to drive gains in the share of safety PIVCs over the forecast period.

more...

Port Needles Market Analysis | China | 2017-2023 | MedCore

The total Chinese market for port needles can be segmented by conventional and safety port needles. In 2016, the largest segment in the total port needle market was the conventional port needles, which accounted for more than 95% of the total market value. However, safety port needles are growing at a much faster pace than conventional port needles. Conventional port needles are expected to continue its dominance in the port needle market in the foreseeable future.

more...

Vascular Access Devices Market Analysis, Size, Trends | Japan | 2017-2023 | MedSuite (Includes 7 Reports)

The Japanese market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), and dialysis catheters.

more...

Dialysis Catheters Market Analysis | Australia | 2017-2023 | MedCore

The Australian dialysis catheter market is composed of short-term (acute) hemodialysis, and long-term (chronic) hemodialysis. The largest segment in the total dialysis catheter market in 2016 was represented by short-term hemodialysis catheters. The second largest market is the long-term hemodialysis catheters. The value of the total dialysis catheter market is expected to grow slightly over the forecast period.

more...

Implantable Ports Market Analysis | Australia | 2017-2023 | MedCore

The Australian market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. The Australian market for implantable ports has been contracting due to a shift away from conventional and towards power-injectable implantable ports. This is further amplified as a result of strong declines in ASPs for power-injectable implantable ports as competitors are expecting strong growth for this segment.

more...

Peripherally Inserted Central Catheters Market Analysis | Australia | 2017-2023 | MedCore

The Australian market for peripherally inserted central catheters (PICCs) is split up into two segments: power-injectable and non-power-injectable PICCs. Non-power-injectable PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties. Power-injectable PICCs have become the standard of care in Australia and in the United States, whereas Japan still prefers conventional PICCs. In 2016, power-injectable PICCs represented less than 70% of the total market for PICCs, with the remaining balance represented by non-power-injectable PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.

more...

Peripheral Intravenous Catheters Market Analysis | Australia | 2017-2023 | MedCore

The Australian market for peripheral intravenous catheters (PIVCs) is split up into two segments: conventional PIVC and safety PIVC. PIVCs are inserted in veins and arteries. An arterial access site is utilized in patients that require blood pressure monitoring. Firmer catheters are preferred for arterial access. A venous access site is utilized for infusing fluids, providing antibiotic treatment and other standard procedures.

more...

Port Needles Market Analysis | Australia | 2017-2023 | MedCore

The total Australian market for port needles can be segmented by conventional and safety port needles. In 2016, the largest segment in the total port needle market was the safety port needles. This segment is experiencing higher unit sales growth than the conventional port needle segment; however, this is slightly balanced by more moderate price declines.

more...

Dialysis Catheters Market Analysis | Japan | 2017-2023 | MedCore

The dialysis catheter market is composed of short-term (acute) hemodialysis, and long-term (chronic) hemodialysis. The largest segment in the total dialysis catheter market in 2016 was represented by short-term hemodialysis catheters. The second largest market is the long-term hemodialysis catheters. The value of the total dialysis catheter market is expected to grow slightly over the forecast period.

more...

Implantable Ports Market Analysis | Japan | 2017-2023 | MedCore

The Japanese market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. The Japanese market for implantable ports has been contracting due to a shift away from conventional and towards power-injectable implantable ports. This is further amplified as a result of strong declines in ASPs for power-injectable implantable ports as competitors are expecting strong growth for this segment.

more...

Peripherally Inserted Central Catheters Market Analysis | Japan | 2017-2023 | MedCore

The Japanese market for peripherally inserted central catheters (PICCs) is split into two segments: power-injectable and non-power-injectable PICCs. Non-power-injectable PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties. Although power-injectable PICCs have become the standard of care in some countries such as the United States, Japan still prefers conventional PICCs. In 2016, power-injectable PICCs represented less than 50% of the total market for PICCs, with the remaining balance represented by non-power-injectable PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.

more...